Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 4, 2025
Clinical consequences of delaying implementation of long-acting antiretroviral therapy for people with HIV and persistent viremia in the USPamela P Pei, Michelle Jones, Ruitian Hu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 15, 2024
Tuberculosis Preventive Treatment for Pregnant People With Human Immunodeficiency Virus in South Africa: A Modeling Analysis of Clinical Benefits and RisksLinzy V Rosen, Acadia M Thielking, Caitlin M Dugdale, et al.
BMJ Open|May 15, 2020
Novel microsimulation model of tobacco use behaviours and outcomes: calibration and validation in a US populationKrishna P Reddy, Alexander J B Bulteel, Douglas E Levy, et al.
Annals of Internal Medicine|January 31, 2022
Cost-Effectiveness of Long-Acting Injectable HIV Preexposure Prophylaxis in the United States : A Cost-Effectiveness AnalysisAnne M Neilan, Raphael J Landovitz, Mylinh H Le, et al.
The Journal of Infectious Diseases|December 8, 2022
A Growing Number of Men Who Have Sex With Men Aging With HIV (20212031): A Comparison of Two Microsimulation ModelsEmily P Hyle, Parastu Kasaie, Eli Schwamm, et al.
The Lancet. Global Health|July 15, 2022
Evaluation of four chemotherapy regimens for treatment of advanced AIDS-associated Kaposi sarcoma in Kenya: a cost-effectiveness analysisEsther E Freeman, Nicole C McCann, Aggrey Semeere, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2020
Cost-effectiveness of a Novel Lipoarabinomannan Test for Tuberculosis in Patients With Human Immunodeficiency VirusKrishna P Reddy, Claudia M Denkinger, Tobias Broger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 18, 2020
Clinical Impact, Costs, and Cost-effectiveness of Expanded Severe Acute Respiratory Syndrome Coronavirus 2 Testing in MassachusettsAnne M Neilan, Elena Losina, Audrey C Bangs, et al.
Medrxiv : the Preprint Server for Health Sciences|August 4, 2020
Clinical Impact, Costs, and Cost-Effectiveness of Expanded SARS-CoV-2 Testing in MassachusettsAnne M Neilan, Elena Losina, Audrey C Bangs, et al.
Pageof 6